BIOspire.ai, with a patent-pending intelligent imaging system based on lens-free holotomographic microscopy technology and AI software, enables, for the first time, complete 3D imaging of living cell cultures. Analysis of living cells, such as determining the DNA fragmentation index of sperm, has not been possible until now.
BIOspire.ai thus achieves what would normally be a classic trade-off: better quality at lower cost. What could be a game-changer in the medical market in itself is further enhanced by the AI and software components. The complementary algorithm, which is continuously trained using the 3D cell data, creates the conditions for novel discoveries in in vitro cell cultures, a possibility currently unavailable with conventional imaging techniques. Furthermore, the solution is sustainable, as the elimination of lenses and solvents allows for more environmentally friendly cell analysis.
BIOspire.ai enables full 3D imaging of living cell cultures for the first time with a patent-pending intelligent imaging system based on lens-free holotomographic microscopy technology and AI software. Analysis of living cells, such as determining the DNA fragmentation index of sperm cells, was previously impossible. BIOspire.ai thus succeeds in what would normally be a classic conflict of goals: better quality at lower cost. What alone could be a game changer in the medical market is further enhanced by the AI and software component. The complementary algorithm, which is continuously trained using the 3D cell data, creates the prerequisite for novel discoveries in in vitro cell cultures, a possibility that is currently not available with conventional imaging methods. In addition, the solution is sustainable, as the elimination of lenses and solvents means that cell analysis can be performed more ecologically.
